Moussa et al. [49] observed significantly lower CSF MMP9 levels in individuals treated with AD, indicating that resveratrol might reduce MMP9 levels and, thus, the permeability of the blood-brain barrier to inflammation. Here, MMP9 is linked to Alzheimer disease.